The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
24913985 |
73 |
SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H. |
Kurukshetra University |
24642566 |
17 |
Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H. |
Kurukshetra University |
23252745 |
86 |
Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives. |
University Of Ljubljana |
19715320 |
87 |
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. |
University Of Florida |
19419206 |
77 |
Identification of 3-acetyl-2-aminoquinolin-4-one as a novel, nonpeptidic scaffold for specific calpain inhibitory activity. |
Ewha Womans University |
17535802 |
91 |
Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing. |
Merck Research Laboratories |
18226527 |
80 |
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. |
Merck Frosst Centre For Therapeutic Research |
19665376 |
48 |
Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C. |
Merck Frosst Canada |
18313933 |
18 |
Substrate optimization for monitoring cathepsin C activity in live cells. |
Genomics Institute Of The Novartis Research Foundation |
17196818 |
90 |
Bicyclic carbamates as inhibitors of papain-like cathepsin proteases. |
The Genomics Institute Of The Novartis Research Foundation |
16647256 |
16 |
Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors. |
Arpida |
16290936 |
69 |
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors? |
Glaxosmithkline |
15896958 |
32 |
Acyclic cyanamide-based inhibitors of cathepsin K. |
Glaxosmithkline |
15837295 |
55 |
A structural screening approach to ketoamide-based inhibitors of cathepsin K. |
Glaxosmithkline |
15780613 |
28 |
Novel and potent cyclic cyanamide-based cathepsin K inhibitors. |
Glaxosmithkline |
15341947 |
57 |
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions. |
Glaxosmithkline |
10052963 |
7 |
New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. |
Albert-Ludwigs-University Of Freiburg |